Authors
Latest:
Federal Trade Commission Votes to Ban Noncompete Clauses Between Employers and WorkersIn online discussion April 23, commissioners cited health care specifically among their reasons for supporting the ban.
Latest:
Eric Simpson, MD, Discusses Recently Announced EADV Data On Tapinarof Cream for AD Down to 2 YearsNew data from ADORING 1 and ADORING 2 show a rapid reduction in pruritus relief as early as 24 hours after the first application.
Latest:
Case 2 Presentation: 58-Year-Old Woman With GPPErin Boh, MD, emphasizes the importance of patient empowerment and physician education surrounding the management of GPP.
Latest:
Late-Breaking Data: Lutikizumab Shows Positive Results in Difficult-to-Treat HS After Failed TNF TherapyAlexandra Kimball, MD, FAAD, reviews late-breaking data at AAD on lutikizumab for hidradenitis suppurativa.
Latest:
Frontline Forum Part 4: Improving Basal Cell Carcinoma ManagementIn the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Latest:
2021’s Top Challenges Facing PhysiciansIn late 2020, our sister publication, Medical Economics®, conducted a Physicians Report asking physician audiences what they thought would be the most challenging issues they will face this year. Here is what the respondents said.
Latest:
Managing Plaque Psoriasis: Expert AdviceTakeaways from a panel discussion on newer biologic therapies to treat plaque psoriasis, and parting advice to other professionals who work in dermatology regarding best practices when using these drugs in their clinics.
Latest:
Shanna Miranti, MPAS, PA-C, Shares Expert Acne and Pediatric Dermatology InsightsAt the SDPA Fall Conference, Miranti emphasized the importance of targeted, comprehensive acne therapies and inspired attendees to embrace pediatric dermatology as a rewarding subspecialty.
Latest:
The Beauty-From-Within Market Continues to GrowThe dietary supplement industry seeks to help consumers age gracefully.
Latest:
Considerations to Best Serve Transgender Patients Seeking Aesthetic CareRonda Farah, MD, and her colleagues reviewed how dermatology providers play an important role in transgender aesthetic care.
Latest:
Top Meeting Takeaways From the Fall Clinical ConferenceClinicians fresh from the Fall Clinical Dermatology Conference discuss their top meeting takeaways and share some recommendations.
Latest:
Psoriasis and Sunburn: New Study Highlights Increased Risk and Clinical ImplicationsSara Osborne, a fourth-year medical student and the lead author on the study, spoke with Dermatology Times on key findings and explain the need for further investigation.
Latest:
Exploring Diet and New Treatments for Hidradenitis SuppurativaFrom diet recommendations to biologic advancements, Jennifer Hsiao, MD, covered essential updates for treating patients with HS.
Latest:
Marcelo Bigal, MD, PhD: VENT-03's Modality Offers Hope for Targeted Therapy in Skin DisordersMarcelo Bigal, MD, PhD, discusses VENT-03's potential as a small molecule therapeutic in dermatology, among other fields.
Latest:
How to Effectively Partner with Patients to Optimize CareCombined, these efforts encourage active participation in the care process and drive sustained behavior change.
Latest:
AAD and VStrong Vitiligo Support Community Receive Inaugural Incyte Ingenuity Awards in VitiligoIncyte representative Todd Edwards discusses how the awards help address challenges faced by patients with vitiligo.
Latest:
Disseminated Erythema Migrans as a Result of Lyme DiseaseA 17-year-old male patient presents with multiple lesions developed on his trunk, face, and extremities that had previously been solitary, red expanding lesion on his right arm at the site of a tick bite that occurred during a hike.
Latest:
Patient Education and Novel Topical Therapies for ADPanelists discuss how age restrictions for PDE4 inhibitors affect treatment decisions for pediatric patients with atopic dermatitis, addressing parental concerns and highlighting the benefits of a single treatment option like roflumilast for managing overlapping inflammatory dermatologic conditions; they also explore current guidelines for corticosteroid use, the potential impact of PDE4 inhibitors on these guidelines, and the future of topical PDE4 inhibitors in dermatology, including the integration of new agents into treatment paradigms and key considerations for patient education and decision-making.
Latest:
The Mainstream Patient: January 3, 2023This week's edition of the Mainstream Patient features stories about dry shampoos that don't contain benzene, the best ferulic acid serums, Hijabi hair care, and more.
Latest:
Customization Drives Pediatric Acne Treatment RegimensTreatment regimens for pediatric acne should consider skin type, ethnicity, disease severity and personal preferences, according to one expert.
Latest:
Addressing Causes of Female Hair Loss and Exploring Preventative MeasuresThis expert review explores the multifaceted causes of female hair loss—hormonal imbalances, inflammation, nutrient deficiencies, aging, and oxidative stress—and explores non-pharmaceutical interventions.
Latest:
Richard Gallo, MD, PhD: Updates on Understanding the Pathophysiology of AcneGallo presented pearls on the pathophysiology of acne and how newer studies have changed acne treatment methodologies at AAD 2024.
Latest:
Proper Coding Gets Practices What They Are OwedA physician’s goal is to care for patients, but a key part of being able to provide that care is the eternal quest for payment. One way to ensure that a practice maximizes its coding regimen is to make sure each session can be efficiently billed.
Latest:
Innovative Insights in Skin Cancer Prognosis, Gene Expression Profiling, and Early Career TipsAaron Farberg, MD, explores advancements in melanoma and cSCC prognostic tools, the role of gene expression profiling in inflammatory diseases, and initiatives aimed at supporting early-career dermatologists at Fall Clinical 2024.
Latest:
Differences in Anti-PD-1/CTLA-4 and Anti-PD-1/LAG-3 Reported in Recent StudyThe study examined the mechanisms of action associated with immune checkpoint inhibitor combination therapies.
Latest:
Tunlametinib Wins Approval in China for NRAS+ Advanced Melanoma After PD-1/PD-L1 TherapyChina’s NMPA has approved tunlametinib for the treatment of patients with NRAS-mutated advanced melanoma after prior anti–PD-1/PD-L1 therapy.
Latest:
Innovative Melanoma Treatment Among NCInnovation's $5.2 Million Research Funding RecipientsMichelle Bolas and Rukiyah T. Van Dross-Anderson, PhD, discuss the significance of NCInnovations’ funding and the clinical impact of Van Dross-Anderson's research in patients with advanced melanoma.
Latest:
Optimizing Patient Communication and Treatment Efficacy Beyond Topical SteroidsOmar Noor, MD, FAAD, hosted a live Case-Based Roundtable discussion with local dermatology clinicians to discuss 2 patients with plaque psoriasis and what would be the ideal topical treatment for each.
